Uncategorized

Antengene Corporation Limited announced that the results of the Phase I/II TORCH-2 study will be presented as a poster discussion during the American Society for Clinical Oncology Annual Meeting, taking place from June 2nd to 6th at the McCormick Place Convention Center in Chicago, IL.

Exploratory feasibility studies of amorphOX® initiated in collaboration with two international biopharmaceutical and vaccine companies.

Swedish Orphan Biovitrum AB announced its report for the first quarter of 2023

Scott Arnold, executive vice president and chief information officer of Tampa General Hospital, has been named a top health care information technology leader by Becker’s Hospital Review on its 2023 “CIOs to Know” list.

Dizal announced that multiple clinical data of its two leading assets – sunvozertinib and golidocitinib have been selected for presentations at the 2023 ASCO, June 2-6, 2023 in Chicago.

Genomma Lab Internacional, S.A.B. de C.V., announced its results for the first quarter ended March 31, 2023.

Thanks to the strong interest from clinicians and patients, we were able to swiftly dose the first patients in the phase 2a part of the combination study with fostrox and Lenvima® in HCC after completed dose escalation.

The operator posted increases in acute care and behavioral volumes while tempering labor costs.

Nari Gopala has previously served in leadership positions at Amazon Web Services, Daybreak Game Company and Sony Online Entertainment.

Buying Risant represents an opportunity for Kaiser to expand its reach nationwide through targeted acquisitions of nonprofit community health systems.